The Hospice Gold Rush: Why Private Equity Wants to Buy Your Last Days
Wall Street has discovered that dying is a highly predictable, incredibly lucrative business model—and your family is the target.
Get Palmelle in your Google results.
One tap. Google shows our reporting higher when you search.
In 2018, a private equity firm bought a midsize hospice provider in the Southeast for $120 million, stripped down its nursing staff, and sold it three years later for $205 million. This is not an isolated corporate success story; it is the standard playbook for the modern American way of dying. Over the last decade, private equity firms have quietly acquired hundreds of hospice providers across the country, transforming a service designed for comfort into a high-margin volume game.
The direct answer
Private equity firms are increasingly acquiring hospice agencies, drawn by the sector's profitability and predictable revenue streams. This shift can lead to a focus on maximizing profits, potentially at the expense of patient care quality and caregiver support, as evidenced by poorer performance on patient experience surveys at PE-owned facilities.
The Business of Dying: Why Hospices Are a Private Equity Magnet
Hospice care, once predominantly a nonprofit endeavor, has become a lucrative target for private equity (PE) investment. Over the past decade, the landscape has shifted dramatically, with PE ownership increasing fivefold, comprising about 15% of hospice agencies by 2022 [c3]. This isn't accidental. The reimbursement structure for hospice, largely driven by Medicare, provides a steady, predictable income stream. For investors, this translates into a relatively low-risk, high-return environment.
This financial predictability is a siren song for PE firms, which often operate on shorter investment horizons. They acquire agencies, streamline operations to boost profit margins, and then look for an exit, whether through a sale to another firm or an initial public offering. The JAMA study highlights this trend, noting that PE and publicly traded companies' hospices underperform compared to other models [c1]. Caregivers have reported more negative experiences at these facilities [c4].
It's a stark contrast to the original ethos of hospice, which was centered on providing comfort and support to individuals and their families during life's final chapter. The focus has subtly, and sometimes not so subtly, shifted from holistic care to financial metrics. This doesn't mean all for-profit hospices are bad, but the PE model inherently introduces a layer of financial pressure that can conflict with patient-centered care.
What Families Aren't Being Told (And What to Look For)
When you're selecting a hospice provider, the conversation often revolves around services offered, staff qualifications, and the emotional support available. What rarely comes up, however, is the ownership structure and its potential implications. Families are generally not informed that their loved one's end-of-life care might be managed by individuals whose primary goal is maximizing shareholder returns.
The data suggests a disconnect. While PE-owned hospices are bringing in profit margins reportedly three times higher than nonprofits [c6], patient experience metrics tell a different story [c1, c4]. This disparity raises serious questions about where resources are being allocated. Are funds being diverted from direct patient care, staff training, or additional support services to satisfy investor demands?
Understanding this dynamic is crucial. It's not about demonizing for-profit entities, but about recognizing that the profit motive, especially when amplified by private equity's aggressive financial strategies, can subtly alter the priorities of an organization. Families deserve to know if the agency they entrust with their most vulnerable moments is primarily accountable to patients or to its investors.
Want more of this?
Mark Palmelle a preferred source and it shows up when you search Google.
The Real Cost of Financializing End-of-Life Care
The increasing financialization of hospice care, driven by private equity, raises concerns about the commodification of a deeply human experience. When the business of dying becomes a primary focus for investors, the intrinsic value of compassionate, patient-centered care can be overshadowed by the pursuit of profit.
This trend is not unique to hospice; it's part of a broader pattern of private equity expanding its reach across the healthcare system [c2]. The opaque nature of many PE ownership structures can make it difficult for families to discern who ultimately controls the decisions affecting their loved one's care [c2]. This lack of transparency can leave families feeling disempowered and uninformed at a time when they need clarity and reassurance the most.
The core issue is the potential conflict of interest. A hospice agency driven by investor expectations might face pressure to admit more patients, increase patient loads for staff, or limit the duration of services to boost revenue. This can lead to burnout among caregivers, reduced quality of care, and a less supportive experience for patients and their families during an already challenging period.
Common mistakes
- Assuming all hospice providers operate with the same core mission.
The influx of private equity has introduced a profit-driven model into hospice care, which can sometimes conflict with the patient-centered ethos. Understanding the ownership structure can reveal potential biases in how care is delivered and prioritized. - Not asking about ownership structure when choosing a hospice provider.
This information is not always readily disclosed, but it's a critical factor in understanding potential operational priorities. Agencies owned by PE firms or publicly traded companies may face different financial pressures than independent or nonprofit agencies.
Frequently asked
Are all for-profit hospices bad?
No. Many for-profit hospices provide excellent care. The concern with private equity ownership is the potential for an intensified focus on profit margins, which studies suggest can negatively impact patient experience metrics compared to other models [c1, c4].
How can I find out who owns a hospice agency?
You can often find this information by directly asking the hospice agency's administrative staff. Publicly traded companies will have their ownership information available through financial disclosures. For private equity-owned entities, it might require a bit more digging, but inquiries about their parent company can often lead to the answer.
Does Medicare dictate the quality of care regardless of ownership?
Medicare sets baseline standards for hospice care, and all certified agencies must meet them. However, these standards may not encompass all aspects of patient and family experience that private equity ownership can influence, such as staff-to-patient ratios, the availability of supplementary services, or the depth of emotional support.
Sources
- JAMA: Performance of Hospice Agencies Owned by Private Equity Firms and Publicly Traded Companies
- Health Affairs: The Growing Presence of Private Equity in U.S. Health Care
- National Library of Medicine: Private Equity Ownership in Health Care
- Healthcare Dive: Hospices owned by private equity, publicly traded companies underperform, study finds
- KFF Health News: How Private Equity Hijacked Health Care
- Center for Economic and Policy Research: Preying on the Dying: Private Equity Gets Rich in Hospice Care
More from Inside the Industry → · Back to Perch · Browse all stories
More of this, in your Google results.
Takes one tap, and it applies everywhere you search — not just this page.